Updated Dec. 6, 2011 at 2:01 p.m.

Premium Lock Samsung venture that includes Quintiles partners with Biogen in $300M deal

Published: 2011-12-06 07:06:00
Updated: 2011-12-06 14:01:34

Quintiles Image 1 of 3 · Next Image…

Samsung Biologics, which Quintiles helped Samsung launch earlier this year, will work with Biogen on a $300 million drug development and manufacturing effort in South Korea. Quintiles owns 10 percent of the Samsing joint venture....

Read More
Read More

Copyright 2014 WRAL TechWire. All rights reserved.
Editor's Blog

Editor's Blog

The latest blog posts from our WRAL TechWire and WRAL editors. Read more articles…

Please Log In to add a comment.

Best of TechWire Insider

Techwire Inside Partners

OUR INSIDERS

Vivek Wadhwa
Commentary
Dr. Mike Walden
Tech economy
Frank Vinluan
Life science
Scroll